Category: Regulations
-
Tracking Algorithms Devised to ID Human Traffickers
Computer scientists developed techniques that help identify the people placing sexual service advertisements by tracing the bitcoin payments for those ads.
-
Trial Underway Testing New ALS Treatment
Patients in a clinical trial testing a treatment for amyotrophic lateral sclerosis, or ALS, began receiving their first doses administered by the study team.
-
Trial to Test Inhaled Insulin, App for Diabetes Mgmt
A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app.
-
Migraine Treatment Shown Effective in Late Trial
Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo.
-
Many Surgical Opioid Drugs Go Unused, Not Disposed
A review of studies that track the use and disposition of opioid pain drugs following surgery shows a large percentage of the pills go unused and few are stored properly.
-
Life Science Execs: Financial, IP Info Top Hacker Targets
Technology executives at pharmaceutical and medical device enterprises in the U.S. say financial and intellectual property assets are their top targets for hackers, according to survey results released today.
-
FDA Clears Algorithm-Assisted Cancer Diagnosis
The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer.
-
Stem Cell Clinics Found Marketing in ClinicalTrials.gov
A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services.
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
America’s Overdose Epidemic In Perspective
This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries.